Unii-928Q33Q049(857402-63-2)
- Name: Unii-928Q33Q049
- Synonyms:17-(Allylamino)-17-demethoxygeldanamycin;Retaspimycin hydrochloride [USAN];UNII-928Q33Q049;NSC-330507;Geldanamycin, 18,21-didehydro-17-demethoxy-18,21-dideoxo-18,21-dihydroxy-17-(2-propenylamino)-, monohydrochloride;17-Allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13,20,22-Trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-19-(prop-2-enylamino)-2-azabicyclo(16.3.1)docosa-1(21),4,6,10,18(22),19-hexen-9-yl carbamate hydrochloride;
- Molecular Formula:C31H45N3O8·ClH
- Molecular Weight:624.175
- CAS Registry Number:857402-63-2
- EINECS:200-258-5
- Melting Point:
- Water Solubility:
Other Product
- 799269-97-9/1H-Pyrrolo[2,3-b]pyridine-3-carbonitrile, 5-(3-furanyl)-
- 799269-88-8/1H-Pyrrolo[2,3-b]pyridine-3-carbonitrile, 5-(2-thienyl)-
- 706812-04-6/Benzamide, 4-[[9-(1,1-dimethylethyl)-2-oxo-3-[4-(trifluoromethoxy)phenyl]-1,3-diazaspiro[5.5]undec-1-yl]methyl]-N-2H-tetrazol-5-yl-
- 846550-95-6/L-Prolinamide, N-methyl-L-alanyl-3-methyl-L-valyl-N-[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]- (9CI)
- 845745-37-1/L-Prolinamide, N-methyl-L-alanyl-3-methyl-L-valyl-N-[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]- (9CI)
- 477793-57-0/Carbamic acid, N-[(1S)-2-[[(1S,2R)-1-[(3,5-difluorophenyl)methyl]-3-[[(3-ethylphenyl)methyl]amino]-2-hydroxypropyl]amino]-2-oxo-1-[[(1-propylbutyl)sulfonyl]methyl]ethyl]-, 3-pyridinylmethyl ester
- 477790-92-4/Carbamic acid, N-[(1S)-2-[[(1S,2R)-1-[(3,5-difluorophenyl)methyl]-3-[[(3-ethylphenyl)methyl]amino]-2-hydroxypropyl]amino]-2-oxo-1-[[(1-propylbutyl)sulfonyl]methyl]ethyl]-, 3-pyridinylmethyl ester, HCl Salt
- 978-62-1/IMD-0354
- 212631-67-9/PD 184161
- 954406-32-7/Acetamide, 2-[4-chloro-2-(3-chloro-5-cyanobenzoyl)phenoxy]-N-[3-fluoro-4-(2-hydroxy-2-methylpropoxy)-2-methylphenyl]-
- 1160597-06-7/CYT 387
- 867331-64-4/TG 100572 (Hydrochloride)
- 1018069-81-2/TG 100801 (Hydrochloride)
- 885482-95-1/SKS-927
- 473727-83-2/(R)-2-hydroxy-N,N-dimethyl-3-(2-(1-(5-methylfuran-2-yl)propylamino)-3,4-dioxocyclobut-1-enylamino)benzamide
- 159633-92-8/MK-677, HCl salt
- 1001350-96-4/BMS-754807
- 728033-96-3/OSI-930
- 692737-80-7/TKI 258
- 857402-63-2/Unii-928Q33Q049
- 871575-98-3/(2R)-[N-(Benzyloxycarbonyl)-D-phenylalanyl-L-prolylamino]-4-methoxybutylboronic acid sodium salt
- 667917-16-0/L-Prolinamide, N-[(phenylmethoxy)carbonyl]-D-phenylalanyl-N-[(1S)-1-borono-4-methoxybutyl]- (9CI)
- 942999-67-9/Bicyclo[2.2.2]octane-1-acetic acid, 4-[4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]- ，AcOH salt
- 433937-74-7/2-Azetidinecarboxamide, N-[[4-(aminoiminomethyl)phenyl]methyl]-1-[(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyacetyl]-, (2S)-
- 433937-93-0/AZD-0837
- 945667-22-1/Saxagliptin hydrate
- 478644-12-1/GW 813893
- 218298-21-6/Razaxaban
- 201933-41-7/YM-60828
- 850649-61-5/ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA)